CRISPR Therapeutics AG | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (42)

Latest Posts

About This Stock More About This Stock
Bull Of The Day: Crispr Therapeutics
Article By: Zacks Investment Research
Monday, December 11, 2023 6:43 AM EST
CRISPR Therapeutics (CRSP) just made history on Friday with the first FDA-approved gene-editing medicine based on the Nobel Prize-winning discovery that targets disease with the billion-year old defense mechanism bacteria use to battle viruses.
In this article: CRSP Also: VRTX, EDIT
Read
Gene Therapy Breakthroughs On The Horizon
Article By: Nelson Alves
Monday, August 21, 2023 3:00 PM EST
Vertex Pharmaceuticals and CRISPR Therapeutics, alongside bluebird bio, are penning a new chapter in the story of gene therapy for sickle cell disease.
In this article: VRTX, CRSP
Read
Thoughts For Thursday: Back From The Holiday With Caution
Article By: TalkMarkets DailyTalk
Thursday, July 6, 2023 6:27 AM EST
Caution is perhaps what was reflected in yesterday's back from the holiday trading. First there is the question of upcoming Fed action and second there is the visit of Secretary Yellen to China.
In this article: DAX, QQQ, IWM, GERN, PACB, XLV, CRSP, META Also: GXC, SMH, BWA, GNRC, LVS, USO, XBI
Read
What Is CRISPR And Why Should Your Portfolio Care?
Article By: Fred Fuld III
Sunday, June 25, 2023 3:01 PM EST
CRISPR Therapeutics continues to be at the forefront of CRISPR-based therapeutics development. It's the first, and largest, but not the only player.
In this article: NVS, EDIT, NTLA, CRSP
Read
Top CRISPR Stocks
Article By: Fred Fuld III
Saturday, February 11, 2023 9:09 PM EST
CRISPR is a narrow niche of the biotechnology industry, but it could become the fastest growing and most significant of all the biotech businesses.
In this article: EDIT, NTLA, CRSP Also: NVS
Read

Latest Tweets for $CRSP

No tweets yet!

PARTNER HEADLINES